Healthcare Stocks
Entities in this sector develop clinical therapeutics, manufacture medical delivery systems, and provide high-acuity facility management across the global care continuum. Revenue models range from speculative R&D pipelines dependent on regulatory milestones to steady-state manufacturing contracts and per-diem reimbursement for post-acute services.
As of Oct 23, 2026, Healthcare has 1083 US-listed companies worth $10.7T combined. The median member moved +1.3% over the past week; ISRG led among the 25 largest at +6.0% and TMO trailed at -2.3%.
Companies in Healthcare
- LLY – Eli Lilly and Company, $1.1T
- JNJ – Johnson & Johnson, $645B
- ABBV – AbbVie Inc, $505B
- UNH – UnitedHealth Group Incorporated, $381B
- PG – Procter & Gamble Company, $364B
- MRK – Merck & Company Inc, $363B
- NVS – Novartis AG ADR, $287B
- AZN – AstraZeneca PLC, $266B
- TMO – Thermo Fisher Scientific Inc, $249B
- AMGN – Amgen Inc, $237B
- LIN – Linde plc Ordinary Shares, $235B
- GILD – Gilead Sciences Inc, $193B
- ABT – Abbott Laboratories, $177B
- NVO – Novo Nordisk A/S, $172B
- PFE – Pfizer Inc, $171B
- WELL – Welltower Inc, $171B
- DHR – Danaher Corporation, $162B
- ISRG – Intuitive Surgical Inc, $160B
- VRTX – Vertex Pharmaceuticals Inc, $136B
- BMY – Bristol-Myers Squibb Company, $129B
- MDT – Medtronic PLC, $122B
- CVS – CVS Health Corp, $121B
- SYK – Stryker Corporation, $118B
- MCK – McKesson Corporation, $117B
- GSK – GlaxoSmithKline PLC ADR, $103B
- HCA – HCA Healthcare, Inc., $102B
- SNY – Sanofi ADR, $99.7B
- ELV – Elevance Health Inc, $96.6B
- CI – Cigna Corp, $83.5B
- REGN – Regeneron Pharmaceuticals Inc, $82.9B
- MRNA – Moderna Inc, $79.9B
- BSX – Boston Scientific Corp, $66.7B
- COR – Cencora Inc., $65B
- TAK – Takeda Pharmaceutical Co Ltd ADR, $64.7B
- CAH – Cardinal Health Inc, $59.2B
- NTRA – Natera Inc, $57.9B
- ARGX – argenx NV ADR, $54.9B
- BDX – Becton Dickinson and Company, $54.6B
- GALDY – GALDERMA GROUP AG, $54B
- EW – Edwards Lifesciences Corp, $51.9B
- HUM – Humana Inc, $50.6B
- A – Agilent Technologies Inc, $48.8B
- TEVA – Teva Pharma Industries Ltd ADR, $46B
- MDLN – Medline Inc. Class A Common Stock, $45.9B
- IQV – IQVIA Holdings Inc, $45.8B
- HLN – Haleon plc, $45.6B
- WAT – Waters Corporation, $44.9B
- IDXX – IDEXX Laboratories Inc, $44.6B
- VTR – Ventas Inc, $43.8B
- ONC – BeiGene, Ltd., $43B
- ILMN – Illumina Inc, $40.7B
- RVMD – Revolution Medicines Inc, $40.2B
- KVUE – Kenvue Inc., $37.6B
- BIIB – Biogen Inc, $37B
- RPRX – Royalty Pharma Plc, $36.8B
- KMB – Kimberly-Clark Corporation, $36.6B
- RMD – ResMed Inc, $35.6B
- CNC – Centene Corp, $35.2B
- ALC – Alcon AG, $34.1B
- ZTS – Zoetis Inc, $33.9B
- MTD – Mettler-Toledo International Inc, $33.5B
- GEHC – GE HealthCare Technologies Inc., $32.5B
- ALNY – Alnylam Pharmaceuticals Inc, $30B
- DXCM – DexCom Inc, $29.6B
- WST – West Pharmaceutical Services Inc, $27.7B
- ROIV – Roivant Sciences Ltd, $27.1B
- GMAB – Genmab AS, $26.9B
- DGX – Quest Diagnostics Incorporated, $26.9B
- LH – Laboratory Corporation of America Holdings, $26.7B
- PHG – Koninklijke Philips NV ADR, $26.3B
- UTHR – United Therapeutics Corporation, $25.1B
- CHD – Church & Dwight Company Inc, $24.9B
- INCY – Incyte Corporation, $23.7B
- BNTX – BioNTech SE, $22.9B
- STE – STERIS plc, $22.6B
- GH – Guardant Health Inc, $21.9B
- THC – Tenet Healthcare Corporation, $21.6B
- VTRS – Viatris Inc, $21.2B
- INSM – Insmed Inc, $20.4B
- ZBH – Zimmer Biomet Holdings Inc, $18.8B
- FTV – Fortive Corp, $18.3B
- MEDP – Medpace Holdings Inc, $18.3B
- DD – Dupont De Nemours Inc, $18.2B
- RGA – Reinsurance Group of America, $17.8B
- RVTY – Revvity Inc., $17.7B
- CRL – Charles River Laboratories, $16.6B
- EXEL – Exelixis Inc, $16.2B
- ASND – Ascendis Pharma AS, $16B
- SOLV – Solventum Corp., $14.9B
- NPXYY – Nippon Sanso Holdings Corp., $14.8B
- OHI – Omega Healthcare Investors Inc, $14.8B
- NBIX – Neurocrine Biosciences Inc, $14.6B
- ICLR – ICON PLC, $14.3B
- HALO – Halozyme Therapeutics Inc, $14.1B
- JAZZ – Jazz Pharmaceuticals PLC, $13.9B
- BBIO – BridgeBio Pharma Inc, $13.4B
- BAX – Baxter International Inc, $13.3B
- DOC – Healthpeak Properties Inc, $13.1B
- GL – Globe Life Inc, $13B
- SNN – Smith & Nephew SNATS Inc, $12.9B
- PEN – Penumbra Inc, $12.8B
- EHC – Encompass Health Corp, $12.4B
- SMMT – Summit Therapeutics PLC, $12.3B
- BTSG – BrightSpring Health Services, Inc. Common Stock, $12B
- DVA – DaVita HealthCare Partners Inc, $11.9B
- FMS – Fresenius Medical Care Corporation, $11.8B
- COO – The Cooper Companies, Inc, $11.7B
- AVTR – Avantor Inc, $11.7B
- AHR – American Healthcare REIT, Inc., $11.6B
- CORT – Corcept Therapeutics Incorporated, $11.6B
- TECH – Bio-Techne Corp, $11.4B
- RGEN – Repligen Corporation, $11.3B
- ELAN – Elanco Animal Health, $11.3B
- ALGN – Align Technology Inc, $11B
- RDY – Dr. Reddy’s Laboratories Ltd ADR, $11B
- UHS – Universal Health Services Inc, $11B
- GMED – Globus Medical, $10.9B
- MOH – Molina Healthcare Inc, $10.9B
- BMRN – Biomarin Pharmaceutical Inc, $10.8B
- GKOS – Glaukos Corp, $10.4B
- QGEN – Qiagen NV, $10.4B
- ENSG – The Ensign Group Inc, $10.4B
- PODD – Insulet Corporation, $10.3B
- OSCR – Oscar Health Inc, $10.3B
- MDGL – Madrigal Pharmaceuticals Inc, $10B
- PCVX – Vaxcyte Inc, $9.9B
- TWST – Twist Bioscience Corp, $9.9B
- TXG – 10X Genomics Inc, $9.8B
- BIO – Bio-Rad Laboratories Inc, $9.6B
- KRYS – Krystal Biotech Inc, $9.6B
- HSIC – Henry Schein Inc, $9.6B
- KYMR – Kymera Therapeutics Inc, $9.3B
- PTGX – Protagonist Therapeutics Inc, $9B
- CAI – Caris Life Sciences, Inc. Common Stock, $9B
- HNGE – Hinge Health, Inc., $8.9B
- IBRX – Immunitybio Inc, $8.8B
- BRKR – Bruker Corporation, $8.7B
- SYRE – Spyre Therapeutics Inc., $8.7B
- CYTK – Cytokinetics Inc, $8.5B
- CTRE – CareTrust REIT Inc., $8.5B
- ARWR – Arrowhead Pharmaceuticals Inc, $8.2B
- ATR – AptarGroup Inc, $8.1B
- TGTX – TG Therapeutics Inc, $8.1B
- HQY – HealthEquity Inc, $8B
- ABVX – Abivax SA American Depositary Shares, $7.7B
- AXSM – Axsome Therapeutics Inc, $7.6B
- PACS – PACS Group, Inc., $7.6B
- ALKS – Alkermes Plc, $7.4B
- ARE – Alexandria Real Estate Equities Inc, $7.4B
- IONS – Ionis Pharmaceuticals Inc, $7.3B
- PRAX – Praxis Precision Medicines Inc, $7.2B
- AMRX – Amneal Pharmaceuticals, Inc. Class A Common Stock, $7.1B
- CHE – Chemed Corp, $6.8B
- LNTH – Lantheus Holdings Inc, $6.5B
- IOVA – Iovance Biotherapeutics Inc, $6.4B
- KNSA – Kiniksa Pharmaceuticals Ltd, $6.3B
- RYTM – Rhythm Pharmaceuticals Inc, $6.3B
- BLCO – Bausch + Lomb Corp, $6.2B
- HR – Healthcare Realty Trust Incorporated, $6.2B
- LGND – Ligand Pharmaceuticals Incorporated, $6.1B
- DOCS – Doximity Inc, $5.9B
- IMVT – Immunovant Inc, $5.9B
- MANE – Veradermics, Incorporated, $5.8B
- BLTE – Belite Bio Inc ADR, $5.8B
- GRAL – GRAIL, LLC, $5.7B
- WAY – Waystar Holding Corp. Common Stock, $5.6B
- TFX – Teleflex Incorporated, $5.5B
- STVN – Stevanato Group SpA, $5.5B
- RDNT – RadNet Inc, $5.5B
- COGT – Cogent Biosciences Inc, $5.5B
- KOD – Kodiak Sciences Inc, $5.4B
- HAE – Haemonetics Corporation, $5.4B
- MMSI – Merit Medical Systems Inc, $5.4B
- MIRM – Mirum Pharmaceuticals Inc, $5.3B
- CGON – CG Oncology, Inc. Common stock, $5.3B
- PTCT – PTC Therapeutics Inc, $5.3B
- ORKA – Oruka Therapeutics, Inc., $5.2B
- GRFS – Grifols SA ADR, $5.2B
- MMED – MiniMed Group, Inc. Common Stock, $5.2B
- SRRK – Scholar Rock Holding Corp, $5.1B
- ERAS – Erasca Inc, $5.1B
- SHC – Sotera Health Co, $5B
- SBRA – Sabra Healthcare REIT Inc, $5B
- NOVT – Novanta Inc, $5B
- TVTX – Travere Therapeutics Inc, $4.9B
- BLLN – BillionToOne, Inc. Class A Common Stock, $4.8B
- CRSP – Crispr Therapeutics AG, $4.8B
- RGC – Regencell Bioscience Holdings Ltd, $4.8B
- OPCH – Option Care Health Inc, $4.7B
- LFST – Lifestance Health Group Inc, $4.6B
- HTFL – Heartflow, Inc. Common Stock, $4.4B
- DFTX – Definium Therapeutics, Inc., $4.4B
- CVSA – Covista Inc., $4.4B
- EWTX – Edgewise Therapeutics Inc, $4.3B
- ITGR – Integer Holdings Corp, $4.3B
- DNTH – Dianthus Therapeutics Inc., $4.3B
- LIVN – LivaNova PLC, $4.3B
- INDV – Indivior PLC Ordinary Shares, $4.2B
- ARQT – Arcutis Biotherapeutics Inc, $4B
- ICUI – ICU Medical Inc, $4B
Showing the 200 largest of 1083 members by market cap.